FDA Inspection 1033886 — Park Avenue Compounding
The FDA completed an inspection of Park Avenue Compounding on Nov 16, 2017 in Saint Louis, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Nov 16, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saint Louis, MO (United States)